Rab6 Regulation of Rhodopsin Transport in Drosophila*

Kiran M. ShettyDagger , Phani Kurada§, and Joseph E. O'Tousa

From the Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Rab6 is a GTP binding protein that regulates vesicular trafficking within the Golgi and post-Golgi compartments. We overexpressed wild-type, a GTPase defective (Q71L), and a guanine nucleotide binding defective (N125I) Rab6 protein in Drosophila photoreceptors to assess the in vivo role of Rab6 in the trafficking of rhodopsin and other proteins. Expression of Drab6Q71L greatly reduced the steady state levels of two rhodopsins, Rh1 and Rh3, whereas Drab6wt and Drab6N125I showed weaker effects. Analysis of a strain carrying Rh1 rhodopsin under a heat shock promoter showed that Drab6Q71L, but not Drab6wt or Drab6N125I, prevents the maturation of rhodopsin beyond an immature 40 kDa form. Drab6Q71L is a GTPase defective mutant, indicating that anterograde transport of rhodopsin requires Rab6 GTPase function. The three Drab6 strains had no effect on the expression of several other photoreceptor proteins. The Drab6Q71L photoreceptors show marked histological defects at young ages and degenerate over a two week time span. These results establish that rhodopsin is transported via a Rab6 regulated pathway and that defects in trafficking pathways lead to retinal degeneration.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Members of the Rab family of small GTPases are localized in distinct subcellular compartments (1), and within these compartments they regulate vesicular trafficking by cycling between GTP- and GDP-bound forms (2). A general model of Rab function has emerged in which a complex of Rab-GDP and guanine nucleotide dissociation inhibitor (GDI)1 is maintained in the cytosol. On binding of this complex to the donor membrane, GDI is displaced and GDP is exchanged for GTP. Rab-GTP is recruited onto the transport vesicle, which buds from the donor membrane and then associates with the target membrane. The Rab-GTP is thought to mediate fusion of the vesicle through interactions with effector molecules on the target membrane. It is not known whether GTP hydrolysis of the Rab-GTP is required for vesicle fusion or occurs after fusion. After GTP hydrolysis, Rab-GDP is retrieved from the target membrane by GDI and recycled to the donor membrane (3-5).

The study of point mutations in several rab genes affecting amino acids essential for guanine nucleotide interactions has documented the importance of the Rab-guanine nucleotide interactions in Rab function (6-8). The Rab6 protein is likely involved in intra-Golgi transport. A GTPase defective Rab6 greatly reduced transport of the proteins between cis/medial and late Golgi compartments in mammalian cell culture (9). More recently, Martinez et al. (8) found that overexpression of wild-type Rab6 and a GTPase-defective Rab6 redistributed a trans-Golgi protein to the ER membrane compartment.

Biochemical studies using specialized cells, however, have suggested a role for Rab6 in post-Golgi transport. Rab6 is associated with post-Golgi vesicles in Torpedo marmorata electrocytes (10), hypothalamic neuronal cells (11), and frog retinal cells (12). The studies with frog retinal cells suggested that the Rab6 protein is associated with rhodopsin-containing vesicles that exit from the trans-Golgi on their way to the rod outer segment.

The Drosophila photoreceptor provides an excellent experimental system to study Rab6 function in rhodopsin membrane trafficking, given the availability of mutations in rhodopsin and other genes that impede rhodopsin maturation. Many of these mutations result in age-dependent degeneration of photoreceptors, suggesting that correct rhodopsin trafficking is critical to maintenance of photoreceptor stability. Some human retinal diseases caused by rhodopsin mutations, may also be due to improper rhodopsin trafficking within the photoreceptor (13). In addition, an inherited form of choroideremia results from a defective Rab escort protein-1, establishing that defects in Rab protein function are involved in other human degenerative diseases (14).

We established an in vivo system to study the role of Rab6 in the trafficking of rhodopsin and other photoreceptor proteins. Our results suggest that Rab6 is required for anterograde rhodopsin transport through the ER-Golgi complex. Further, defects in Rab6 trafficking also trigger retinal degeneration, strengthening the tie between defects in the rhodopsin maturation pathway and photoreceptor degeneration.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cloning of Drab6-- Degenerate primers based on the conserved DTAGQ and NKXD sequence motifs found in all Rab proteins were used to RT-PCR amplify rab sequences from total Drosophila RNA. RNA was isolated following methods of Cathala et al. (15). RT-PCR reaction was performed as specified by the RT-PCR reaction kit manufacturer (Perkin-Elmer). The 170-base pair fragments recovered from these reactions were cloned and sequenced to identify the Drosophila rab6 sequence (Drab6). The 170-base pair fragment of Drab6 was then used to isolate the entire rab6 gene from a Drosophila genomic library. In situ hybridizations, carried out as described by Ashburner (16), placed the gene at 33C/D on the standard Drosophila salivary chromosome map.

Site-directed Mutagenesis and Construction of Transgenic Flies-- Site-directed mutagenesis was used to create Drab6N125I (AAC to ATC) and Drab6Q71L (CAG to CTG). The coding sequence of the two mutants and Drab6wt were placed under the control of the ninaE promoter and inserted in a P-element transformation vector (17). Drosophila transgenic flies were made by standard means (18) using the null mutant ninaEoI17 as the recipient strain. Four independent lines were obtained for Drab6wt and Drab6N125I and two independent lines were obtained for Drab6Q71L. All lines for each construct showed similar levels of Rab6 expression and rhodopsin defects as described in this paper.

Generation of Rab6 Antibody-- A polyclonal antibody to Drosophila Rab6 was generated using the GEX glutathione S-transferase system (19). To generate the antibody, a 243-base pair region coding for a C-terminal region of Rab6 (amino acids 129-208) was placed in the pGEX-3 vector. The fusion protein was collected on glutathione-agarose beads and then recovered from the beads by eluting in 8 M urea, 1 mM glycine, 1 mM EDTA, 100 mM beta -mercaptoethanol, 0.1 M Tris, pH 8.0. The fusion protein was dialyzed overnight in 20 mM Tris, pH 8.0, and used to immunize mice.

Phenotypic Characterization-- Proteins from fly heads were extracted in 60 mM Tris, pH 6.8, 25% glycerol, 2% SDS, 14.4 mM beta -mercaptoethanol, and 0.1% bromphenol blue, separated by SDS-polyacrylamide gel electrophoresis (20) on 4-15%, 10%, or 12% gels, and transferred onto nitrocellulose membranes (Amersham Pharmacia Biotech) in 19 mM Tris, 150 mM glycine, 20% methanol. Proteins were detected using the polyclonal antibodies directed against Rh1 or Rh3 opsin,2 RdgB (21), Trp (22), and NinaC (23). Protein was detected using the ECL system (Amersham Pharmacia Biotech).

To analyze the transient expression of rhodopsin, we used a stock designated hs-ninaE-hsv tag 14. This stock contained an HSV (epitope identified in herpes simplex virus glycoprotein D)-tagged rhodopsin under the heat shock promoter (24). Flies heterozygous for the tagged rhodopsin and the respective Drab6 P-transgene were heat shocked for 1 h at 37 °C and placed at room temperature (22 °C) for the indicated time. Protein separation, transfer, and detection were performed as stated above, using a monoclonal antibody directed against the HSV tag (Novagen Corp.).

Electroretinography (ERG) recordings (as described in Larrivee et al. (25)) were performed on 2-day-old white eyed flies reared in a 12-h light/12-h dark cycle.

Electron microscopy was performed as described by Washburn and O'Tousa (26). All genotypes were white eyed and maintained in a 12-h light/12-h dark cycle. The control, Drab6wt and Drab6N125I flies were homozygous for ninaE+, whereas the Drab6Q71L flies were heterozygous for ninaE+. 16 days old Drab6wt flies heterozygous for rhodopsin were also sectioned and provided the same results (data not shown).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Drab6 Mutants Reduce Rhodopsin Levels-- We used a PCR-based approach to initiate a study of Drosophila rab6 and identified the rab6 gene previously named Drab6 by Satoh et al. (27). We created two Drab6 mutations, the GTPase defective (Drab6Q71L) and the guanine nucleotide binding defective (Drab6N125I), by in vitro mutagenesis. These two mutants and the wild-type (Drab6wt) coding sequences were placed under the control of the ninaE promoter to allow specific and high levels of expression only in the Drosophila R1-R6 class of photoreceptor cells (28). Protein blotting experiments using Drosophila Rab6 antibody confirmed that transgenic flies carrying these genes made large amounts of the Rab6 proteins (Fig. 1). The majority of the Rab6 protein in the transgenic flies possessed a higher apparent molecular mass than that seen in control wild-type flies, corresponding to a nonprenylated Rab6 protein (9). The lipid modified form of Rab6 was also easily observed in these transgenic flies. We estimate that 32 times more lipid-modified Rab6 protein was detected in flies expressing the Drab6wt constructs than in wild-type control flies. Similar high levels of modified Rab6 protein (37 times more protein in Drab6N125I, and 57 times more protein in Drab6Q71L) was observed in the other transgenic flies.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Rab6 levels in wild-type, Drab6wt, Drab6N125I, and Drab6Q71L flies. Flies homozygous for the designated Drab6 P-transgenes were examined for Rab6 content by immunoblotting. Protein samples from five heads were used in the three transgenic flies, although 5, 10 or 15 flies were used for wild-type flies as designated in the figure. Blot was probed with polyclonal Drosophila Rab6 antibody. The apparent molecular masses of unmodified and modified Rab6 are 28 and 26 kDa, respectively.

To look for generalized defects in photoreceptor function because of expression of these Rab6 proteins, we assayed the light response by ERG (Fig. 2). All strains show a robust response to light stimuli. A prolonged depolarizing afterpotential (PDA) is seen in the ERG, on exposure to blue light, when a substantial amount of rhodopsin is converted to an active metarhodopsin form (29). Control flies generate a complete PDA, and Drab6wt and Drab6N125I flies show a slight defect in the PDA maintenance. Drab6Q71L flies completely lack a PDA. Given the importance of high rhodopsin levels in generating a PDA, these results suggested that Drab6wt and Drab6N125I have minor effects on rhodopsin expression, and Drab6Q71L flies possess much lower levels of rhodopsin. Rhodopsin protein levels were examined by Western blot analysis to assess the effects of the Drab6 strains (Fig. 3). Rhodopsin levels are dramatically reduced in Drab6Q71L (12% of wild type). There is a more modest reduction in the Drab6wt and Drab6N125I flies (76 and 74% of wild-type levels, respectively).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   ERG responses of wild-type, Drab6wt, Drab6N125I, and Drab6Q71L flies. Flies were white eyed, 2 to 3 days post-eclosion, and heterozygous for the R1-R6 rhodopsin gene (ninaE+/ninaEI17). Heterozygosity for the ninaE gene lowers rhodopsin to approximately 50%, sufficient to elicit a full prolonged depolarizing afterpotential, denoted "PDA" in the wild-type trace, following a bright blue light stimuli. All tracings consists of an experimental regime in which an orange light stimulus (approximately 3 × 104 microwatts cm-2) was followed by two blue light stimuli (approximately 5 × 103 microwatts cm-2) and then subjected to another orange light stimulus. Stimulus duration was 5 s with 20 s between stimuli.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 3.   Rhodopsin levels in wild-type, Drab6wt, Drab6N125I, and Drab6Q71L flies. Shown is the immunoblot analysis of rhodopsin levels from head protein extracts of five flies tested. All flies were 2-3 days post-eclosion and heterozygous for a wild-type rhodopsin gene. Rhodopsin was detected by a polyclonal rhodopsin antibody. The estimation of protein levels are averages derived from densitometric analysis of two independent experiments.

Drab6Q71L Inhibits the Anterograde Transport of Rhodopsin-- We analyzed the effects of the Drab6 strains in an experimental protocol designed to document defects in the rhodopsin maturation pathway (24, 30) (see also "Experimental Procedures"). In these experiments, flies carried a rhodopsin gene tagged by an HSV epitope expressed from a heat shock promoter. Expression of this rhodopsin gene occurs only during a 37 °C heat shock, allowing the fate of rhodopsin synthesized during a restricted time window to be assessed. For the study here, we constructed strains carrying both the heat shock-controlled rhodopsin gene and each of the three Drab6 genes.

A strain containing the heat shock-controlled rhodopsin gene but no Drab6 construct served as the control in these experiments. In the absence of heat shock, no HSV-tagged rhodopsin could be detected in protein blotting experiments (Fig. 4A). Two h following the heat shock, the rhodopsin is detected as a 40-kDa species (open arrow) as well as several slightly higher molecular mass forms. 14.5 h after the pulse, rhodopsin is still present in the 40-kDa form but now is also detected in lower molecular mass bands (35-38 kDa). At 24 h after the heat shock, most of the rhodopsin is found in the 35-kDa form (filled arrow). This 35-kDa form has the same mobility as the major species of rhodopsin found in flies expressing the HSV-tagged rhodopsin from the ninaE promoter, hence we consider it the mature form. The strains containing the Drab6wt and Drab6N125I genes had the same profile as the control strain (Fig. 4, C and D). The Drab6Q71L flies, however, showed defects in rhodopsin maturation (Fig. 4B). Two h after heat shock, the majority of the rhodopsin was detected in the 40-kDa form, as expected from the analysis of the other strains. However, at 14.5, 24, and 48 h after heat shock, the 40-kDa rhodopsin remained as the predominant species. The data establish that the Drab6Q71L mutant is defective in processing the immature 40-kDa rhodopsin species into the mature 35-kDa form.


View larger version (97K):
[in this window]
[in a new window]
 
Fig. 4.   Immunoblot analysis of the transient expression of a HSV-tagged rhodopsin in wild-type, Drab6wt, Drab6N125I, and Drab6Q71L flies. All flies were heterozygous for both the heat shock promoter-rhodopsin-HSV construct and the designated Drab6 P-transgenes. Flies were reared at 22 °C except during a 1-h 37 °C heat shock, and protein samples prepared at the stated times following heat shock. Proteins from twelve heads were used in each lane and probed with monoclonal anti-HSV antibodies. The open arrow and closed arrows on each image are at the expected migration position of the 40-kDa (immature) and the 35-kDa (mature) rhodopsin, respectively.

Drab6 Mutants Affect Opsin but Not Other Photoreceptor Proteins-- In Drosophila six different opsins are expressed in subsets of the photoreceptor cells. To test the effects of the Drab6 constructs on a different rhodopsin, we misexpressed the Rh3 rhodopsin in R1-R6 photoreceptor cells (31). Western blot analysis of these strains (Fig. 5A) showed that Rh3 protein levels were reduced in all three Drab6 transgenic strains compared with controls. As with expression of the Rh1 (NinaE) protein, Rh3 levels were most reduced in the Drab6Q71L flies, with the other two lines showing a significant, but smaller, reduction of protein.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 5.   Immunoblot analysis of photoreceptor proteins in wild-type, Drab6wt, Drab6N125I, and Drab6Q71L flies. Results from immunoblot probing for Rh3 (A), RdgB (B), Trp (C), and NinaC (D) proteins. Five heads of 2-3 days post-eclosion flies were used in all experiments. In panel A, all flies are heterozygous for a transgene directing Rh3 rhodopsin expression in the R1-R6 photoreceptor cells. The estimation of protein levels shown below the immunoblot image in panels A, B, and C are averages derived from densitometric analysis of two independent experiments, whereas protein levels in panel D are the sum of both NinaC proteins in the blot shown. In panels B, C, and D, control refers to wild-type flies, whereas null alleles used were rdgB2, trpcm, ninaCP235. Other lanes are wild type for RdgB, Trp, or NinaC, but carry the indicated Drab6 gene.

We examined the protein levels of two other photoreceptor membrane proteins involved in phototransduction to determine whether the Drab6Q71L effect was specific to rhodopsin. RdgB is a membrane protein that is localized to the photoreceptor sub rhabdomeric-cisternae (21), and Trp is a Ca2+ channel protein that co-localizes with rhodopsin in the rhabdomeres (32). Neither RdgB (Fig. 5B) nor Trp (Fig. 5C) protein levels were dramatically affected in any Drab6 strain. Similarly, the protein levels of the membrane-associated ninaC-encoded cytoskeletal photoreceptor proteins (Fig. 5D) were not affected.

Retinal Degeneration Occurs in Drab6 Transgenic Lines-- Electron microscopy was carried out to assess the changes in photoreceptor ultrastructure caused by overexpression of the Drab6 genes. Photoreceptors R1-R6 express the ninaE-encoded Rh1 rhodopsin and, therefore, also express the Drab6 genes constructed in this study. The R7 cell, shown in Fig. 6, A-C, will not express the Drab6 transgenes and therefore serves as a convenient control in all micrographs. Three-day old control photoreceptors are shown in Fig. 6A. Drab6wt and Drab6N125I R1-R6 photoreceptors (data not shown) are similar in structure to the control. Drab6Q71L flies (Fig. 6B), however, show a marked reduction in the R1-R6 rhabdomeres volume. The area of the R1-R6 rhabdomeres in the Drab6Q71L rhabdomeres is similar in size to the R7 rhabdomere, even though the wild-type R1-R6 rhabdomeres are 70% larger (33). Drab6Q71L R1-R6 cells possess an abnormal accumulation of membranes at the base of the rhabdomeres (arrow in Fig. 6D). Some R1-R6 photoreceptors show loosely organized rhabdomeric membranes (arrow in Fig. 6E). Another striking feature is the frequent appearance of "whorl" membranes (34) within the cell (arrow in Fig. 6F).


View larger version (162K):
[in this window]
[in a new window]
 
Fig. 6.   Electron micrographs of Drab6Q71L photoreceptors. All flies, raised in a 12-h light/12-h dark cycle, were processed for histology at 2-3 days post-eclosion (A, B, and D-F) and 14-16 days post-eclosion (C). In panels A-C, the R7 photoreceptor cell is identified. The R7 cell does not express the Drab6 transgenes and therefore constitutes an internal control. Micrographs shown are: control wild type (A), Drab6Q71L (B-F). Arrows in panels C-F indicate morphological defects in Drab6Q71L as described in the text. The bar in the bottom left corner of micrographs A-C is 5 µm and in micrographs D-F is 2 µm.

Histological analysis on older flies indicated that overexpression of all three Drab6 genes triggered retinal degeneration. A cross section of an ommatidial unit of a 16-day old Drab6Q71L is shown in Fig. 6C (data not shown for Drab6wt and Drab6N125I). Some R1-R6 photoreceptors of all the strains lacked rhabdomeric membranes (cell bodies marked with arrowheads in Fig. 6C).

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Rab6 Role in Rhodopsin Maturation-- A major objective of this study was to investigate the role of Rab6 in rhodopsin maturation. Protein blotting experiments and ERG analysis established that Drab6Q71L flies possessed about 12% of the wild-type steady state levels of rhodopsin. Drab6wt and Drab6N125I flies possess about 75% of the wild-type rhodopsin levels. The only deficit in the ERG traces can be attributed to the reduction in rhodopsin content, indicating that overexpression of the Rab6 proteins did not have a debilitating effect on the physiology of these photoreceptor cells.

Analysis of rhodopsin transport using a heat shock-regulated promoter demonstrated that in wild-type, Drab6wt, and Drab6N125I photoreceptors, rhodopsin matures to its final 35-kDa form within 24 h. In contrast, rhodopsin maturation is severely impaired in Drab6Q71L, showing little progression beyond the 40-kDa intermediate form. Previous work established that the 40-kDa rhodopsin is a high mannose intermediate found within the ER. The 40-kDa rhodopsin requires the ninaA encoded cyclophilin (35) and retinal addition (36, 37) to exit the ER. Our results show that Rab6Q71L blocks rhodopsin transport prior to its progression into the cis or medial Golgi compartment that contains the mannosidase which acts on the high mannose rhodopsin intermediate (38, 39). These results are consistent with a role of Rab6 in intra-Golgi transport. Although we have no data suggesting Rab6 in post-Golgi events as suggested by a study on frog retinal cells (12), our analysis does not rule out a second independent role of Rab6.

A recent study showed that transient expression of Rab1N124I protein prevents rhodopsin maturation beyond the 40-kDa intermediate (40), similar to the phenotype observed in the Drab6Q71L mutant. It is striking that dominant mutants of the first two Rab proteins studied in the Drosophila photoreceptor appear to affect similar stages of rhodopsin maturation. However, rhodopsin likely remains in a 40-kDa form as it trafficks from the ER to the cis or medial Golgi where modifications of the oligosaccharide side chain is thought to occur. Therefore, multiple Rabs, including the Rab1 and Rab6 proteins, may be required in these steps. The expression of Rh3 rhodopsin was also markedly reduced in the Drab6Q71L flies, and smaller effects were seen in the two other Drab6 strains. On the other hand, none of the Drab6 strains affected the levels of other photoreceptor proteins tested. These results suggest that rhodopsin transport is more sensitive to defects in the Rab6-regulated pathway, with alternative maturation pathways available for other photoreceptor membrane proteins. An alternative explanation, that RdgB and Trp are transported via the Rab6 pathway but nonetheless are maintained at normal levels, is only plausible if the stability of these proteins is dramatically increased in Drab6Q71L mutant photoreceptors. Resolution of these issues will likely require the identification and analysis of an in vivo loss of function rab6 mutant.

The Effect of Dominant Forms of Rab6-- By analogy with point mutations of rab6 (9) and other rab genes (6, 41), the Gln to Leu change prevents GTP hydrolysis. Therefore the Rab6Q71L mutant protein will always be bound to GTP. Drab6Q71L is a potent inhibitor of rhodopsin protein transport, which is consistent with the behavior of this mutation in other Rab6 studies (8, 9). If GTP hydrolysis is required for vesicle fusion, as proposed for Rab3a (42), Drab6Q71L is expected to prevent the fusion of vesicles with their target membrane. Our results showing that the Drab6Q71L form inhibits rhodopsin transport is consistent with a role for GTP hydrolysis to promote anterograde transport of rhodopsin-bearing vesicles. Alternatively, Rab6 in its GTP form could be a positive regulator of the retrograde transport, as proposed by Martinez et al. (8, 9). According to this notion, Drab6Q71L could increase the flow of retrograde transport and indirectly disrupt the anterograde pathway, resulting in inhibition of protein transport. However, this model was originally proposed to rationalize results showing that Rab6wt has similar effects as Rab6Q72L that were not confirmed in our experiments.

We also documented an inhibition of Rh1 and Rh3 rhodopsin expression in the Drab6wt and Drab6N125I strains. However, the heat shock analysis indicates that Drab6wt and Drab6N125I have little or no inhibitory effects on the maturation of the 40- to the 35-kDa form of Rh1 rhodopsin. Thus, the mechanism of Drab6wt and Drab6N125I action is distinct from that of Drab6Q71L. The Drab6wt and Drab6N125I proteins might have an effect on later stages of rhodopsin maturation, but it is also possible that the reduction in rhodopsin is a consequence of secondary effects associated with the overexpression of these proteins. All Rab proteins require isoprenylation to be functional (43). When we overexpress Rab6 in photoreceptors, 25-35% of the protein is isoprenylated. The failure to completely modify the large amount of Rab6 found in these flies suggests that overexpression has overwhelmed the Rab geranylgeranyl transferase pathway responsible for the prenylation of all Rab proteins (46). Therefore, overexpression of Rab6 may also inhibit the modification, and therefore the activity, of other Rab proteins. Thus, the defects seen in photoreceptors overexpressing Rab6wt or Rab6N125I may not be directly attributable to the altered Rab6 activity.

It is surprising that Drab6wt and Drab6N125I have similar effects. The Asn to Ile mutation is thought to create a defect in guanine nucleotide binding. In mammalian cell culture, the Asn to Ile mutant of Rab2 and Rab3a proteins show similar inhibitory effect on secretion as observed for the Gln to Leu mutations (6, 42). On the other hand, the Asn to Ile mutation in rab6 increased secretion rate (7). The lack of a mutant phenotype in our studies does not result from Rab6N125I protein instability since protein immunoblots show high levels of this protein. It appears that the Rab6N125I protein, perhaps because of lack of nucleotide binding, is unable to participate in the rab6 cycle.

Effects of Rab6 on Photoreceptor Degeneration-- Overexpression of any form of Rab6 caused retinal degeneration, but the rate and severity of degeneration depended upon the form of Rab6. At young ages, Drab6Q71L photoreceptors already show structural differences that distinguish it from Drab6wt and Drab6N125I photoreceptors. The most striking difference is a much smaller volume occupied by the R1-R6 rhabdomeres. This phenotype is shared with mutant ninaE (33, 44), ninaA (35), ninaC (45, 46), as well as vitamin A deprived flies (47). All these flies possess reduced rhodopsin content, suggesting that the reduced size of the rhabdomere in the Drab6Q71L mutant is likely the result of poor rhodopsin maturation.

The Drab6Q71L photoreceptors exhibit other ultrastructural defects, most notably an accumulation of disorganized membranes within the cytoplasm as well as "whorl" membranes thought to represent membrane recycling processes (34). Satoh et al. (40) documented a similar phenotype in the Drosophila rab1N124I mutant. Consistent results are also obtained in mammalian cell culture. Martinez et al. (8) documented that overexpression of the rab6Q72L mutant allows the mixing of ER and Golgi membrane compartments, and morphological changes of the ER/Golgi are noted in other studies using lovastatin to limit prenylation of Rab proteins (48). Thus, the abnormal membrane accumulation documented in Drab6Q71L photoreceptors may result from abnormal Golgi organization, and the defects in rhodopsin maturation may be a secondary consequence of this defect. On the other hand, our data are not compatible with a catastrophic defect in ER-Golgi transport in Drab6Q71L photoreceptors, as these photoreceptors retain normal physiological function, and other membrane proteins are detected at normal levels.

Dominant rhodopsin mutants cause age-dependent retinal degeneration as a result of defects in rhodopsin transport (30, 49). We initiated this study to examine the role of Rab6 in rhodopsin transport and to explore an in vivo experimental system to study the trafficking of rhodopsin. Our results establish the importance of Rab6-regulated trafficking mechanisms in both rhodopsin biogenesis and maintenance of photoreceptor morphology and function.

    ACKNOWLEDGEMENTS

We thank Sheila Adams for assistance with histology, Kathleen Mitchell and Tim Tonini for help in construction of the transgenic Drosophila strains, Paul Vieta for help with ERGs, Michael Nonet and Koichi Ozaki for sharing their Rab6 sequence data prior to publication, Craig Montell and David Hyde for antibodies, Steve Britt for the Rh3 transgenic strain, and Tracy Washburn and Michael Zimmerman for critical reading of this manuscript.

    FOOTNOTES

* This work was supported in part by Grant EY06808 from the National Institutes of Health (to J. E. O.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported during part of this project by a Fight for Sight Fellowship, Prevent Blindness America.

§ Present address: Cutaneous Biology Research Center, Massachusetts General Hospital, Bldg. 149, 13th St., Charlestown, MA 02129.

To whom correspondence should be addressed. Tel.: 219-631-6093; Fax: 219-631-7413; E-mail: o'tousa.1{at}nd.edu.

The abbreviations used are: GDI, guanine nucleotide dissociation inhibitor; RT-PCR, reverse transcription-polymerase chain reaction; ERG, electroretinography; PDA, prolonged depolarizing afterpotential; ER, endoplasmic reticulum.

2 T. Washburn, M. Serikaku, and J. O'Tousa, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Novick, P., and Brennwald, P. (1993) Cell 75, 597-601[Medline] [Order article via Infotrieve]
  2. Zerial, M., and Stenmark, H. (1993) Curr. Opin. Cell Biol. 5, 613-620[Medline] [Order article via Infotrieve]
  3. Novick, P., and Zerial, M. (1997) Curr. Opin. Cell Biol. 9, 496-504[CrossRef][Medline] [Order article via Infotrieve]
  4. Pfeffer, S. (1994) Curr. Opin. Cell Biol. 6, 522-526[Medline] [Order article via Infotrieve]
  5. Nuoffer, C., and Balch, W. E. (1994) Annu. Rev. Biochem. 63, 949-990[CrossRef][Medline] [Order article via Infotrieve]
  6. Tisdale, E. J., Bourne, J. R., Khosravi-Far, R., Der, C. J., and Balch, W. E. (1992) J. Cell Biol. 119, 749-761[Abstract]
  7. McConlogue, L., Castellano, F., deWit, C., Schenk, D., and Maltese, W. A. (1996) J. Biol Chem. 271, 1343-1348[Abstract/Free Full Text]
  8. Martinez, O., Antony, C., Pehau-Arnaudet, G., Berger, E. G., Salamero, J., and Goud, B. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1828-1833[Abstract/Free Full Text]
  9. Martinez, O., Schimdt, A., Salamero, J., Hoflack, B., Roa, M., and Goud, B. (1994) J. Cell Biol. 127, 1575-1588[Abstract]
  10. Jasmin, B., Goud, B., Camus, G., and Cartaud, J. (1992) Neuroscience 49, 849-855[Medline] [Order article via Infotrieve]
  11. Tixier-Vidal, A., Barret, A., Picart, R., Mayau, V., Vogt, D., Wiedenmann, B., and Goud, B. (1993) J. Cell Sci. 105, 935-947[Abstract/Free Full Text]
  12. Deretic, D., and Papermaster, D. S. (1993) J. Cell Sci. 106, 803-813[Abstract/Free Full Text]
  13. Sung, C.-H., Makino, C., Baylor, D. A., and Nathans, J. (1994) J. Neurosci. 14, 5818-5833[Abstract]
  14. Seabra, M. C., Ho, Y. K., and Anant, J. S. (1995) J. Biol. Chem. 270, 24420-24427[Abstract/Free Full Text]
  15. Cathala, G., Sacouret, B., Mendez, B., West, M., Karin, M., Martial, J. A., and Baxter, J. D. (1983) DNA 2, 329-335[Medline] [Order article via Infotrieve]
  16. Ashburner, M. (1989) Drosophila: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  17. Rubin, G. M., and Spradling, A. C. (1983) Nucleic Acids Res. 11, 6341-6351[Abstract]
  18. Spradling, A. C. (1986) in Drosophila: A Practical Approach (Roberts, D. B., ed), pp. 175-196, IRL Press Limited, Oxford, England
  19. Smith, D. B., and Johnson, K. S. (1988) Gene (Amst.) 67, 31-40[CrossRef][Medline] [Order article via Infotrieve]
  20. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  21. Vihtelic, T. S., Goebl, M., Milligan, S., O'Tousa, J. E., and Hyde, D. R. (1993) J. Cell Biol. 122, 1013-1022[Abstract]
  22. Montell, C., and Rubin, G. M. (1989) Neuron 2, 1313-1323[Medline] [Order article via Infotrieve]
  23. Montell, C., and Rubin, G. M. (1988) Cell 52, 757-772[Medline] [Order article via Infotrieve]
  24. Kurada, P., Tonini, T. D., Serikaku, M. A., Piccini, J. P., and O'Tousa, J. E. (1998) Visual Neurosci. 15, 693-700[CrossRef][Medline] [Order article via Infotrieve]
  25. Larrivee, D. C., Conrad, S. K., Stephenson, R. S., and Pak, W. L. (1981) J. Gen. Physiol. 78, 521-545[Abstract]
  26. Washburn, T., and O'Tousa, J. E. (1992) Genetics 130, 585-595[Abstract/Free Full Text]
  27. Satoh, A., Tokunaga, F., and Ozaki, K. (1997) FEBS Lett. 404, 65-69[CrossRef][Medline] [Order article via Infotrieve]
  28. Mismer, D., and Rubin, G. M. (1987) Genetics 116, 565-578[Abstract/Free Full Text]
  29. Pak, W. L. (1979) in Neurogenetics: Genetic Approaches to the Nervous System (Breakfield, X. O., ed), pp. 67-99, Elsevier-North Holland, New York
  30. Colley, N. J., Cassill, J. A., Baker, E. K., and Zuker, C. S. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3070-3074[Abstract]
  31. Feiler, R., Bjornson, R., Kirshfeld, K., Mismer, D., Rubin, G. M., Smith, D. P., Socolich, M., and Zuker, C. S. (1992) J. Neurosci. 12, 3862-3868[Abstract]
  32. Niemeyer, B. A., Suzuki, E., Scott, K., Jalink, K., and Zuker, C. S. (1996) Cell 85, 651-659[Medline] [Order article via Infotrieve]
  33. Leonard, D. S., Bowman, V. D., Ready, D. F., and Pak, W. L. (1992) J. Neurobiol. 23, 605-626[Medline] [Order article via Infotrieve]
  34. Blest, A. D. (1980) in The Effects of Constant Light on Visual Processes (Williams, T. P., and Baker, B. W., eds), pp. 217-245, Plenum Press, New York, NY
  35. Colley, N. J., Baker, E. K., Stamnes, M. A., and Zuker, C. S. (1991) Cell 67, 255-263[Medline] [Order article via Infotrieve]
  36. Ozaki, K., Nagatani, H., Ozaki, M., and Tokunaga, F. (1993) Neuron 10, 1113-1119[Medline] [Order article via Infotrieve]
  37. Huber, A., Wolfrum, U., and Paulsen, R. (1994) Eur. J. Cell Biol. 63, 219-229[Medline] [Order article via Infotrieve]
  38. Pelham, H. R. B. (1989) Annu. Rev. Cell Biol. 5, 1-23[CrossRef]
  39. Rothman, J. E., and Orci, L. (1990) FASEB J. 4, 1460-1468[Abstract/Free Full Text]
  40. Satoh, A. K., Tokunaga, F., Kawamura, S., and Ozaki, K. (1997) J. Cell Sci. 110, 2943-2953[Abstract/Free Full Text]
  41. Stenmark, H., Parton, R. G., Steele-Mortimer, O., Lutcke, A., Gruenberg, J., and Zerial, M. (1994) EMBO J. 13, 1287-1296[Abstract]
  42. Johannes, L., Lledo, P.-M., Roa, M., Vincent, J.-D., Henry, J.-P., and Darchen, F. (1994) EMBO J. 13, 2029-2037[Abstract]
  43. Magee, T., and Newman, C. (1992) Trends Cell Biol. 2, 318-323[Medline] [Order article via Infotrieve]
  44. O'Tousa, J. E., Leonard, D. S., and Pak, W. L. (1989) J. Neurogenet. 6, 41-52[Medline] [Order article via Infotrieve]
  45. Matsumoto, H., Isono, K., Pye, Q., and Pak, W. L. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 985-989[Abstract]
  46. Porter, J. A., Hicks, J. L., Williams, D. S., and Montell, C. (1992) J. Cell Biol. 116, 683-693[Abstract]
  47. Sapp, R. J., Christianson, J. S., Maier, L., Studer, K., and Stark, W. S. (1991) Exp. Eye Res. 53, 73-79[Medline] [Order article via Infotrieve]
  48. Ivessa, N. E., Gravotta, D., De Lemos-Chiarandini, C., and Kreibich, G. (1997) J. Biol. Chem. 272, 20828-20834[Abstract/Free Full Text]
  49. Kurada, P., and O'Tousa, J. E. (1995) Neuron 14, 571-579[Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.